EGB Ventures

EGB Ventures is a family office founded by physician-entrepreneur William (Bill) Garner, MD, dedicated to forming, financing, and developing clinical-stage pharmaceutical and biotechnology companies addressing critical unmet medical needs. Rather than solely investing in existing companies, EGB Ventures actively creates new ventures — recruiting executive leadership, securing intellectual property, and providing hands-on strategic and operational guidance through clinical development. The firm operates a co-investment model, partnering with strategic investors to advance portfolio companies toward value inflection points via licensing, M&A, or IPO transactions. Portfolio companies have been listed on the ASX, CSE, TSX, and NASDAQ. Notable ventures include Entropy Neurodynamics (ASX: ENP), focused on psychedelic-based therapies, and Island Pharmaceuticals, targeting antiviral drugs. The firm's track record includes building companies with a combined market value exceeding $1 billion. EGB Ventures is led by a physician-led team combining clinical insight with commercial and financial expertise.